TimothyEugeneAlbertsonMD

Critical Care Medicine, Pleural Disease

Distinguished Professor of Medicine, Emergency Medicine, Anesthesiology and Pharmacology/Toxicology, School of Medicine UC Davis

Dr. Albertson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4150 V St Ste 3100
UC Davis Medical Center
Sacramento, CA 95817
Phone+1 916-734-8596

Fax+1 916-734-7906

University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1981 - 1983
University of California Davis HealthResidency, Internal Medicine, 1980 - 1983
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1979 - 1980
University of California Davis HealthResidency, Emergency Medicine, 1980
University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1979
University of Arizona College of Medicine-TucsonInternship, Internal Medicine, 1977 - 1978
University of California, Davis, School of MedicineClass of 1977

America's Top Doctors Castle Connolly, 2002-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Fellow (FRCP) Royal College of Physicians (London), 2005
Super Doctor SuperDoctors.com
Fellow (FCCM) American College of Critical Care Medicine
Fellow (FACEP) American College of Emergency Physicians
Join now to see all

PubMed

Update on the pharmacological treatment of chronic obstructive pulmonary disease.
Madeleine R Jacques, Brooks T Kuhn, Timothy E Albertson
Expert Opinion on Pharmacotherapy. 2024-10-01
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF).
Katyayini Aribindi, Gabrielle Y Liu, Timothy E Albertson
Expert Review of Clinical Pharmacology. 2024-09-01
Using the ROX Index to Predict Treatment Outcome for High-Flow Nasal Cannula and/or Noninvasive Ventilation in Patients With COPD Exacerbations.
Brett Z Schaeffer, Sarina A Fazio, Jacqueline C Stocking, Jason Y Adams, Anna Liu
Respiratory Care. 2024-08-24